Filtered By:
Cancer: Myeloma
Countries: Spain Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis
CONCLUSION: This study demonstrated that hematologic cancer patients were more susceptible to a severe COVID-19 than patients without blood cancer. Thus, the management of COVID-19 in these patients requires much more attention, and their screening should perform regularly.PMID:35385130 | DOI:10.1002/jcla.24387
Source: Clinical Lymphoma and Myeloma - April 6, 2022 Category: Cancer & Oncology Authors: Adel Naimi Ilya Yashmi Reza Jebeleh Mohammad Imani Mofrad Shakiba Azimian Abhar Yasaman Jannesar Mohsen Heidary Reza Pakzad Source Type: research
